Tillots and Numab to collaborate to develop inflammatory bowel disease treatments
9 June 2015 | By
Tillotts Pharma and Numab are to collaborate to develop and commercialise new antibody-based therapies for people with inflammatory bowel disease...
List view / Grid view
News
FDA Grants Orphan Status for ATX-F8-117 for the treatment of haemophilia A patients in the US
9 June 2015 | By Victoria White
Apitope’s product candidate ATX-F8-117 has been granted Orphan Drug Status by the FDA for the treatment of patients with haemophilia A in the US...
Calcineurin inhibitor-based medications may protect against Alzheimer’s disease
9 June 2015 | By Victoria White
A new study has revealed that calcineurin inhibitor-based medications, such as Tacrolimus or cyclosporine, may also protect against Alzheimer’s disease...
FDA and EMA grants orphan drug designation to recAP for the treatment of hypophosphatasia
9 June 2015 | By Victoria White
AM‐Pharma has announced that the FDA and EMA have both granted orphan designation status to recAP for the treatment of hypophosphatasia...
Fibrocell and Intrexon announce positive preclinical data for FCX-007 in RDEB
9 June 2015 | By Victoria White
Fibrocell and Intrexon have announced positive preclinical data for FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa...
Myxoma virus kills cancer cells while blocking graft-versus-host disease in bone marrow transplants
8 June 2015 | By Victoria White
Researchers have discovered that the myxoma virus can kill some kinds of cancer cells while eliminating a complication of bone marrow transplants...
MSD, Illumina and Genea form the Global Fertility Alliance
8 June 2015 | By Victoria White
The Global Fertility Alliance is a new collaboration to advance excellence in fertility technologies within the assisted reproductive treatment laboratory...
Lab-on-a-Chip, Microfluidics, Point-of-Care Diagnostics and Global Health, The Road to Diagnostics Congress
8 June 2015 | By Select Biosciences
Select Biosciences is delighted to announce that its flagship congress now in its 7th year in San Diego, California, USA is being held September 28-30, 2015...
Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features international roster of speakers.
8 June 2015 | By Select Biosciences
Select Biosciences is delighted to announce that its Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features all the international key opinion leaders in the organ-on-a-chip/body-on-a-chip field as well as 3D-bioprinting fields...
Drug abuse triggers regulations to push the development of abuse-free opioid formulations
8 June 2015 | By Victoria White
A $10 billion market exists for a company able to develop a novel, targeted opioid therapy that excludes side effects such as addiction and constipation...
T cell exhaustion study has possible implications for cancer and antiviral therapies
4 June 2015 | By Victoria White
When the T cells of your immune system are forced to deal over time with cancer or a chronic infection, they can develop "T cell exhaustion"...
AmpliPhi’s bacteriophage manufacturing facility receives cGMP certification
4 June 2015 | By Victoria White
AmpliPhi's production facility in Ljubljana has been cleared by JAZMP to manufacture bacteriophages under current Good Manufacturing Practices standards...
VBI Vaccines presents data supporting the use of its eVLP platform to develop a novel HCV vaccine candidate
4 June 2015 | By Victoria White
VBI Vaccines has delivered a presentation that supports the potential use of its eVLP platform in the development of a novel Hepatitis C vaccine candidate...
Amended Celgene and bluebird bio collaboration to focus on the development of anti-BCMA products
4 June 2015 | By Victoria White
The existing global collaboration between Celgene and bluebird bio has been amended and restated to focus on developing product candidates targeting BCMA...
Triple treatment keeps lung cancer from coming back
4 June 2015 | By Victoria White
Lung cancer often returns and the recurring cancer is often resistant to the chemotherapy and other drugs that originally drove it into remission...